Trial of Neoadjuvant Durvalumab Plus Docetaxel, Oxaliplatin, S-1 Followed by Surgery and Adjuvant Durvalumab Plus S-1 Chemotherapy in Potentially Resectable MMR Proficient Gastric or Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT04221555 · COMPLETED
Trial details
- NCT number
- NCT04221555
- Sponsor
- Asan Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-13
- Primary completion
- 2025-04-08
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.